Efficacy of Nivolumab in a Patient with Metastatic Renal Cell Carcinoma and End-Stage Renal Disease on Dialysis: Case Report and Literature Review
Treatment of patients with metastatic renal cell carcinoma (mRCC) and end-stage renal disease (ESRD) on dialysis poses a therapeutic challenge, particularly as this patient group was excluded from the pivotal clinical trials. In addition, there is uncertainty regarding drug dosing/pharmacokinetics,...
Saved in:
Main Authors: | Jawaher Ansari, Muhammad Ali, Ashraf Farrag, Arwa M. Ali, Abdulaziz Alhamad |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Case Reports in Immunology |
Online Access: | http://dx.doi.org/10.1155/2018/1623957 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trace elements in children with pre-dialysis and end-stage renal disease
by: Alsalam Asmaa Abd, et al.
Published: (2024-01-01) -
Pathologic Complete Response to Neoadjuvant Nivolumab/Ipilimumab in a Patient with Metastatic Renal Cell Carcinoma
by: Taylor C. Peak, et al.
Published: (2020-01-01) -
Safe Administration of anti-PD-L1 Atezolizumab in a Patient with Metastatic Urothelial Cell Carcinoma and End-Stage Renal Disease on Dialysis
by: Alessandro Parisi, et al.
Published: (2019-01-01) -
Peritoneal dialysis in an end-stage renal disease patient with massive ascites and primary liver cancer
by: Lulu Sun, et al.
Published: (2024-12-01) -
Pruritus Features in Children with End-Stage Renal Disease Underwent Dialysis: A Cross-Sectional Study
by: Mehryar Mehrkash, et al.
Published: (2021-01-01)